The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/38170
StudyName: Eligibility Breast Cancer NCT01928615
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 24.09.2019
License: Creative Commons BY 4.0

----

Description: 
A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01928615
